Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
$5.64
+6.3%
$4.60
$3.42
$25.50
$3.10M0.75235,353 shs39,774 shs
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
$1.52
-5.5%
$1.83
$1.46
$188.51
$2.27M0.38658,189 shs59,999 shs
Cutera, Inc. stock logo
CUTR
Cutera
$0.04
-63.9%
$0.04
$0.09
$1.87
$787K1.362.68 million shs27.70 million shs
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
$3.30
+2.8%
$3.83
$2.90
$240.10
$2.43M-0.21140,638 shs69,204 shs
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
0.00%-0.57%-0.57%-0.57%-41.28%
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
0.00%-9.04%-15.71%-61.58%-98.90%
Cutera, Inc. stock logo
CUTR
Cutera
0.00%0.00%0.00%0.00%-97.61%
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
0.00%-12.30%+3.55%-25.35%-99.97%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
1.0023 of 5 stars
0.05.00.00.01.20.01.3
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
1.0937 of 5 stars
0.05.00.00.02.80.00.6
Cutera, Inc. stock logo
CUTR
Cutera
N/AN/AN/AN/AN/AN/AN/AN/A
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
2.9709 of 5 stars
3.54.00.00.02.80.01.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
0.00
N/AN/AN/A
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
0.00
N/AN/AN/A
Cutera, Inc. stock logo
CUTR
Cutera
2.50
Moderate Buy$3.007,592.31% Upside
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
3.00
Buy$50.001,415.61% Upside

Current Analyst Ratings Breakdown

Latest CUTR, BJDX, BBLG, and NDRA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/21/2025
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
Ascendiant Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$75.00 ➝ $50.00
(Data available from 6/20/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
N/AN/AN/AN/A$8.39 per shareN/A
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
$250K9.09N/AN/A$10.34 per share0.15
Cutera, Inc. stock logo
CUTR
Cutera
$155.21M0.01N/AN/A($8.62) per share0.00
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
N/AN/AN/AN/A$4.77 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
-$4.11MN/A0.00N/AN/AN/A-130.21%-119.39%8/8/2025 (Estimated)
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
-$7.72M-$379.74N/AN/AN/A-322.46%-262.96%N/A
Cutera, Inc. stock logo
CUTR
Cutera
-$162.83M-$6.58N/AN/AN/A-84.86%N/A-45.07%8/6/2025 (Estimated)
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
-$11.51M-$172.04N/AN/AN/AN/A-140.96%-106.14%8/13/2025 (Estimated)

Latest CUTR, BJDX, BBLG, and NDRA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/13/2025Q1 2025
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
N/A-$3.37N/A-$3.37N/AN/A
5/12/2025Q1 2025
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
-$2.88-$1.92+$0.96-$0.32N/AN/A
3/31/2025Q4 2024
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
-$36.00-$112.37-$76.37-$112.37N/AN/A
3/31/2025Q4 2024
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
-$4.10-$9.40-$5.30-$20.78N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
N/AN/AN/AN/AN/A
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
N/AN/AN/AN/AN/A
Cutera, Inc. stock logo
CUTR
Cutera
N/AN/AN/AN/AN/A
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
N/A
12.60
12.60
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
N/A
2.71
2.71
Cutera, Inc. stock logo
CUTR
Cutera
N/A
2.88
1.86
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
N/A
3.85
3.85

Institutional Ownership

CompanyInstitutional Ownership
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
34.30%
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
18.47%
Cutera, Inc. stock logo
CUTR
Cutera
90.70%
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
1.19%

Insider Ownership

CompanyInsider Ownership
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
6.10%
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
0.08%
Cutera, Inc. stock logo
CUTR
Cutera
0.42%
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
0.04%
CompanyEmployeesShares OutstandingFree FloatOptionable
Bone Biologics Corp. stock logo
BBLG
Bone Biologics
2550,000512,000Not Optionable
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
91.49 million1.49 millionNot Optionable
Cutera, Inc. stock logo
CUTR
Cutera
46020.19 million20.10 millionOptionable
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
20740,000738,000Not Optionable

Recent News About These Companies

ENDRA Life Sciences Inc Registered Shs NDRA
ENDRA Life Sciences Reports Q3 2024 Results and Progress
ENDRA Life Sciences Inc trading halted, news pending
Why ENDRA Life Sciences (NDRA) Stock Is Up 140%

New MarketBeat Followers Over Time

Media Sentiment Over Time

Bone Biologics stock logo

Bone Biologics NASDAQ:BBLG

$5.64 +0.34 (+6.32%)
As of 02:07 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.

Bluejay Diagnostics stock logo

Bluejay Diagnostics NASDAQ:BJDX

$1.52 -0.09 (-5.59%)
As of 02:08 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Bluejay Diagnostics, Inc., a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, it develops IL-6 for the monitoring of disease progression in critical care; as well as hsTNT/I and NT-proBNP for the monitoring of patients acuity with chest pain. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.

Cutera stock logo

Cutera NASDAQ:CUTR

$0.04 -0.07 (-63.86%)
Closing price 03/12/2025
Extended Trading
$0.04 0.00 (0.00%)
As of 03/12/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cutera, Inc. provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform. It also offers truSculpt, a high-powered radio frequency system designed for circumferential reduction, lipolysis, and deep tissue heating and treat all skin types; Secret RF, a fractional RF microneedling device that delivers heat into the deeper layers of the skin using controlled RF energy; and Enlighten SR/III, a laser platform with a dual wavelength for multi-colored tattoo removal, and the treatment of benign pigmented lesions and acne scars. In addition, the company provides Excel HR, a hair removal solution for all skin types; xeo, a multi-application platform for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity; and Secret DUO, two dual non-ablative fractional technologies that can be used individually or in combination to target a variety of aesthetic concerns and skin conditions on all skin types with little to no downtime. Further, it offers its products through direct sales and services, and network of distributors and direct international sales. Cutera, Inc. was incorporated in 1998 and is headquartered in Brisbane, California.

ENDRA Life Sciences stock logo

ENDRA Life Sciences NASDAQ:NDRA

$3.30 +0.09 (+2.77%)
As of 02:02 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.